Eckert & Ziegler SE, a provider of isotope technology, has announced a strategic partnership with Bicycle Therapeutics, a pharmaceutical company developing Bicycle Radio Conjugates (BRC molecules). Under the agreement, Eckert & Ziegler will supply various radioisotopes and provide development and manufacturing
Recipharm, a global CDMO, has officially opened its new Pilot Scale Development Centre in Germany. The facility, first announced as an investment last year, is now fully operational with cutting-edge equipment aimed at advancing pharmaceutical product development and manufacturing. The
Scorpius Holdings, Inc., a contract development and manufacturing organization (CDMO), has announced its engagement of Alliance Global Partners (A.G.P.) to evaluate potential strategic alternatives. The move aligns with the company’s objective to strengthen its market position and identify opportunities for long-term growth
Bavarian Nordic A/S has announced a strategic partnership with Biological E. Limited (BE) to enhance access to its chikungunya vaccine in low- and middle-income countries (LMICs). This collaboration marks a significant step in addressing the public health burden of chikungunya
ProRx Pharma, a cGMP, 503B outsourcing facility, has expanded its operations to meet the growing demand for compounded medications, particularly those on the FDA’s drug shortage list. The company has doubled its existing pharmaceutical and manufacturing facility to a total
Körber has partnered with Amazon Web Services (AWS) to provide fully managed, cloud-based manufacturing execution system (MES) solutions for the life sciences sector. The move aligns with industry trends, as pharmaceutical manufacturers increasingly seek flexible, scalable, and cost-effective digital solutions to improve supply
“Other CDMOs couldn’t handle these products, but we figured it out through technical grit and deep expertise,” explains Jackie Klecker, Executive Vice President of Quality and Development Services at Lifecore Biomedical. In a CDMO Live Preview episode of the PharmaSource
Thermo Fisher Scientific Inc. has signed a definitive agreement to acquire Solventum’s Purification & Filtration business for approximately $4.1 billion in cash. The deal, expected to close by the end of 2025, will enhance Thermo Fisher’s bioproduction capabilities and expand its filtration technology offerings.
WuXi Biologics has successfully completed the Good Manufacturing Practice (GMP) inspection conducted by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities, MFG2 and MFG5, in Wuxi, China. The inspection concluded without issues, reinforcing the company’s adherence
WuXi XDC Cayman Inc., a contract research, development, and manufacturing organisation (CRDMO) specialising in ADCs and bioconjugates, has signed an expanded Memorandum of Understanding (MOU) with LigaChem Biosciences. The agreement broadens their existing collaboration to further accelerate the development of next-generation
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
